Qimin He

923 total citations
22 papers, 760 citations indexed

About

Qimin He is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Qimin He has authored 22 papers receiving a total of 760 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 9 papers in Genetics and 9 papers in Oncology. Recurrent topics in Qimin He's work include Chronic Lymphocytic Leukemia Research (8 papers), Cancer-related Molecular Pathways (6 papers) and Glycosylation and Glycoproteins Research (3 papers). Qimin He is often cited by papers focused on Chronic Lymphocytic Leukemia Research (8 papers), Cancer-related Molecular Pathways (6 papers) and Glycosylation and Glycoproteins Research (3 papers). Qimin He collaborates with scholars based in Sweden, China and United Kingdom. Qimin He's co-authors include Sven Skog, Eric O. Aboagye, Frank Brady, Henryk Barthel, Sajinder K. Luthra, Oliver C. Hutchinson, Safiye Osman, Pat Price, Marcel Cleij and David R. Collingridge and has published in prestigious journals such as Cancer Research, Sustainability and Biochimica et Biophysica Acta (BBA) - General Subjects.

In The Last Decade

Qimin He

21 papers receiving 737 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qimin He Sweden 13 300 289 260 191 165 22 760
Suriya Jeyapalan United States 13 262 0.9× 109 0.4× 372 1.4× 263 1.4× 92 0.6× 33 926
Mauricio Catalá Cuba 8 354 1.2× 155 0.5× 116 0.4× 156 0.8× 219 1.3× 16 622
C.J.A. Punt Netherlands 11 299 1.0× 72 0.2× 161 0.6× 216 1.1× 88 0.5× 26 624
Mayra Ramos Cuba 16 461 1.5× 268 0.9× 112 0.4× 297 1.6× 180 1.1× 33 827
Anuradha Bulusu United States 12 188 0.6× 88 0.3× 104 0.4× 69 0.4× 129 0.8× 19 576
Panteleimon Kountourakis Greece 14 376 1.3× 75 0.3× 70 0.3× 141 0.7× 219 1.3× 32 627
Olga Torres Cuba 8 374 1.2× 177 0.6× 104 0.4× 230 1.2× 140 0.8× 12 595
Angela Pennisi United States 15 479 1.6× 89 0.3× 120 0.5× 71 0.4× 345 2.1× 40 902
Sabine Harig Germany 10 270 0.9× 59 0.2× 137 0.5× 60 0.3× 128 0.8× 12 548
Mischa Houtkamp Netherlands 10 376 1.3× 274 0.9× 43 0.2× 96 0.5× 207 1.3× 16 782

Countries citing papers authored by Qimin He

Since Specialization
Citations

This map shows the geographic impact of Qimin He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qimin He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qimin He more than expected).

Fields of papers citing papers by Qimin He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qimin He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qimin He. The network helps show where Qimin He may publish in the future.

Co-authorship network of co-authors of Qimin He

This figure shows the co-authorship network connecting the top 25 collaborators of Qimin He. A scholar is included among the top collaborators of Qimin He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qimin He. Qimin He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Wang, Peiyao, et al.. (2024). Parental awareness and perspectives on newborn screening in China: a questionnaire-based study. BMC Medical Ethics. 25(1). 140–140.
4.
He, Qimin. (2012). Religious Traditions in Local Communities of China. Pastoral Psychology. 61(5-6). 823–839. 2 indexed citations
5.
He, Qimin, Tommy� Fornander, Hemming Johansson, et al.. (2007). Thymidine kinase 1 in serum predicts increased risk of distant or loco-regional recurrence following surgery in patients with early breast cancer.. PubMed. 26(6C). 4753–9. 54 indexed citations
6.
Zhang, Pingan, Xiaobing Zhang, Sven Skog, et al.. (2006). Thymidine kinase 1: A proliferation marker for determining prognosis and monitoring the surgical outcome of primary bladder carcinoma patients. Oncology Reports. 15(2). 455–61. 37 indexed citations
7.
Leyton, Julius, John P. Alao, Marco Da Costa, et al.. (2006). In vivoBiological Activity of the Histone Deacetylase Inhibitor LAQ824 Is detectable with 3′-Deoxy-3′-[18F]Fluorothymidine Positron Emission Tomography. Cancer Research. 66(15). 7621–7629. 59 indexed citations
8.
Euler, Henrik von, et al.. (2005). Time-dependent RNA degradation affecting cDNA array quality in spontaneous canine tumours sampled using standard surgical procedures. International Journal of Molecular Medicine. 16(6). 979–85. 11 indexed citations
9.
Skog, Sven, et al.. (2005). Expression of cell proliferating genes in patients with non-small cell lung cancer by immunohistochemistry and cDNA profiling. Oncology Reports. 13(5). 837–46. 25 indexed citations
10.
Barthel, Henryk, Meg Perumal, John Latigo, et al.. (2004). The uptake of 3?-deoxy-3?-[18F]fluorothymidine into L5178Y tumours in vivo is dependent on thymidine kinase 1 protein levels. European Journal of Nuclear Medicine and Molecular Imaging. 32(3). 257–263. 106 indexed citations
12.
He, Qimin, M. Mérza, Naining Wang, et al.. (2004). Cytosolic thymidine kinase is a specific histopathologic tumour marker for breast carcinomas.. International Journal of Oncology. 25(4). 945–998. 31 indexed citations
13.
Zhou, Ji, et al.. (2003). Production and characterisation of a novel chicken IgY antibody raised against C-terminal peptide from human thymidine kinase 1. Journal of Immunological Methods. 277(1-2). 157–169. 58 indexed citations
14.
Wu, Jianping, et al.. (2002). A Comparative Study: Immunohistochemical Detection of Cytosolic Thymidine Kinase and Proliferating Cell Nuclear Antigen in Breast Cancer. Cancer Investigation. 20(7-8). 922–931. 23 indexed citations
15.
He, Qimin & Sven Skog. (2002). Involvement of a Substrate Cycle Between Thymidine and Thymidylate in the Regulation of DNA Precursor Pool in Ehrlich Ascites Tumour. Cellular Physiology and Biochemistry. 12(5-6). 305–314. 1 indexed citations
16.
Wang, Naining, Qimin He, Sven Skog, Staffan Eriksson, & Bernhard Tribukait. (2001). Investigation on Cell Proliferation with a New Antibody against Thymidine Kinase 1. Analytical Cellular Pathology. 23(1). 11–19. 32 indexed citations
17.
Wu, Jiangping, et al.. (2001). A new cell proliferating marker: cytosolic thymidine kinase as compared to proliferating cell nuclear antigen in patients with colorectal carcinoma.. PubMed. 20(6C). 4815–20. 22 indexed citations
18.
Nylén, Urban, et al.. (1998). Cisplatin-Induced Inhibition of p34cdc2is Abolished by 5-Fluorouracil. Acta Oncologica. 37(4). 355–363. 3 indexed citations
19.
Skog, Sven, Rolf Lewensohn, Qimin He, Alexander Borg, & Rita Gatti. (1997). Kinetics of G1/S and G2/M transition in X-irradiated ataxia-telangiectasia cells.. PubMed. 21(1). 91–102. 3 indexed citations
20.
He, Qimin, et al.. (1996). Existence of phosphorylated and dephosphorylated forms of cytosolic thymidine kinase (TK1). Biochimica et Biophysica Acta (BBA) - General Subjects. 1289(1). 25–30. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026